Leo O, Foo M, Forman J, Shivakumar S, Rabinowitz R, Bluestone J A
Transplantation Biology Section, National Cancer Institute, Bethesda, MD 20892.
J Immunol. 1988 Jul 1;141(1):37-44.
The present study focused on attempts to correlate the expression of T cell differentiation antigens and development. A series of mAb was developed that recognized an Ly-6.2-linked Ag, Ly-6C.2. These mAb reacted with a subset of peripheral Lyt-2+ T lymphocytes but not Lyt-2+ thymocytes. Functional analysis of the Lyt-2+, Ly-6C.2- and Lyt-2+, Ly-6C.2+ subsets demonstrated that both cell types responded in class I and class II allogeneic MLC as well as in virus-specific cell-mediated cytolysis assay, although precursor frequency analysis suggested that the majority of precursor CTL were Ly-6C.2+. The marker did not appear to represent an activation Ag because Ly-6C.2-, Lyt-2+ precursor CTL generated Ly-6C.2-, Lyt-2+ CTL. Finally, virtually all splenic Lyt-2+ T cells from athymic (nu/nu) mice were Ly-6C.2+ whereas all thymic CTL were Ly-6C.2-. These results suggested that Ly-6C.2+, Lyt-2+ T cells may represent a distinct lineage of Lyt-2+ T cells that can develop in the absence of thymic influence.
本研究着重于尝试将T细胞分化抗原的表达与发育相关联。开发了一系列识别与Ly-6.2相关的抗原Ly-6C.2的单克隆抗体(mAb)。这些单克隆抗体与外周Lyt-2⁺ T淋巴细胞的一个亚群发生反应,但不与Lyt-2⁺胸腺细胞发生反应。对Lyt-2⁺、Ly-6C.2⁻和Lyt-2⁺、Ly-6C.2⁺亚群的功能分析表明,这两种细胞类型在I类和II类同种异体混合淋巴细胞培养(MLC)以及病毒特异性细胞介导的细胞溶解试验中均有反应,尽管前体细胞频率分析表明大多数前体细胞毒性T淋巴细胞(CTL)是Ly-6C.2⁺。该标志物似乎不代表一种活化抗原,因为Ly-6C.2⁻、Lyt-2⁺前体CTL产生Ly-6C.2⁻、Lyt-2⁺ CTL。最后,无胸腺(nu/nu)小鼠的几乎所有脾脏Lyt-2⁺ T细胞都是Ly-6C.2⁺,而所有胸腺CTL都是Ly-6C.2⁻。这些结果表明,Ly-6C.2⁺、Lyt-2⁺ T细胞可能代表了Lyt-2⁺ T细胞的一个独特谱系,其可以在无胸腺影响的情况下发育。